The new coronavirus COVID-19 made Dr. Jag Singh a patient at his own hospital. A lung infection made it difficult for him to breathe. His doctors at Massachusetts General said he needed to make a decision about life support while in intensive care. Then, they offered him a chance to test remdesivir. The experimental drug has had some good results when used against other coronaviruses. Singh, a heart specialist, said yes immediately. COVID-19 patients around the world have been joining remdesivir studies in the past few weeks. The interest has been so great that the U.S. National Institutes of Health is expanding its study. It has nearly reached its first goal of 440 patients. The California company Gilead Sciences makes the drug.
What is Intensive Care?
A special department of a hospital that provides intensive treatment medicine
A special section of a school that teaches critical reading skills
A special department of a day care center for babies with a fever
A special cream for dry skin
What group is expanding its study of this new drug?
A medical center in Arizona
New York Hospital
The U.S. National Institutes of Health
The American Medical Society
The name of the California company that makes the drug featured in this article is called Gilead Sciences .
Johnson & Johnson
Gilead Sciences
Bayer
Astra Zenica